- Home
- YALA vs MNKD Comparison
YALA vs MNKD Comparison
Compare YALA & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YALA
- MNKD
- Stock Information
- Founded
- YALA 2016
- MNKD 1991
- Country
- YALA United Arab Emirates
- MNKD United States
- Employees
- YALA N/A
- MNKD N/A
- Industry
- YALA Computer Software: Programming Data Processing
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- YALA Technology
- MNKD Health Care
- Exchange
- YALA Nasdaq
- MNKD Nasdaq
- Market Cap
- YALA 1.1B
- MNKD 1.2B
- IPO Year
- YALA 2020
- MNKD 2004
- Fundamental
- Price
- YALA $7.65
- MNKD $3.73
- Analyst Decision
- YALA
- MNKD Buy
- Analyst Count
- YALA 0
- MNKD 6
- Target Price
- YALA N/A
- MNKD $9.17
- AVG Volume (30 Days)
- YALA 836.8K
- MNKD 3.1M
- Earning Date
- YALA 08-11-2025
- MNKD 08-06-2025
- Dividend Yield
- YALA N/A
- MNKD N/A
- EPS Growth
- YALA 14.19
- MNKD 149.32
- EPS
- YALA 0.81
- MNKD 0.11
- Revenue
- YALA $348,190,638.00
- MNKD $301,736,000.00
- Revenue This Year
- YALA $7.52
- MNKD $13.62
- Revenue Next Year
- YALA $6.88
- MNKD $15.18
- P/E Ratio
- YALA $9.62
- MNKD $34.33
- Revenue Growth
- YALA 6.79
- MNKD 21.48
- 52 Week Low
- YALA $3.73
- MNKD $3.38
- 52 Week High
- YALA $9.29
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- YALA 45.09
- MNKD 48.69
- Support Level
- YALA $7.62
- MNKD $3.60
- Resistance Level
- YALA $9.10
- MNKD $3.81
- Average True Range (ATR)
- YALA 0.43
- MNKD 0.17
- MACD
- YALA -0.10
- MNKD -0.00
- Stochastic Oscillator
- YALA 11.83
- MNKD 50.72
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.